Request for Covid-19 Impact Assessment of this Report
The United States Drugs Based on TGF-β1 market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Drugs Based on TGF-β1 market, reaching US$ million by the year 2028. As for the Europe Drugs Based on TGF-β1 landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Drugs Based on TGF-β1 players cover Roche, Shionogi Ltd, , and , etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Drugs Based on TGF-β1 market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
Pirfenidone
Galunisertib
Others
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
IPF
Cancer
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Roche
Shionogi Ltd
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Drugs Based on TGF-β1 Market Size 2017-2028
2.1.2 Drugs Based on TGF-β1 Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Drugs Based on TGF-β1 Segment by Type
2.2.1 Pirfenidone
2.2.2 Galunisertib
2.2.3 Others
2.3 Drugs Based on TGF-β1 Market Size by Type
2.3.1 Drugs Based on TGF-β1 Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Drugs Based on TGF-β1 Market Size Market Share by Type (2017-2022)
2.4 Drugs Based on TGF-β1 Segment by Application
2.4.1 IPF
2.4.2 Cancer
2.4.3 Others
2.5 Drugs Based on TGF-β1 Market Size by Application
2.5.1 Drugs Based on TGF-β1 Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Drugs Based on TGF-β1 Market Size Market Share by Application (2017-2022)
3 Drugs Based on TGF-β1 Market Size by Player
3.1 Drugs Based on TGF-β1 Market Size Market Share by Players
3.1.1 Global Drugs Based on TGF-β1 Revenue by Players (2020-2022)
3.1.2 Global Drugs Based on TGF-β1 Revenue Market Share by Players (2020-2022)
3.2 Global Drugs Based on TGF-β1 Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Drugs Based on TGF-β1 by Regions
4.1 Drugs Based on TGF-β1 Market Size by Regions (2017-2022)
4.2 Americas Drugs Based on TGF-β1 Market Size Growth (2017-2022)
4.3 APAC Drugs Based on TGF-β1 Market Size Growth (2017-2022)
4.4 Europe Drugs Based on TGF-β1 Market Size Growth (2017-2022)
4.5 Middle East & Africa Drugs Based on TGF-β1 Market Size Growth (2017-2022)
5 Americas
5.1 Americas Drugs Based on TGF-β1 Market Size by Country (2017-2022)
5.2 Americas Drugs Based on TGF-β1 Market Size by Type (2017-2022)
5.3 Americas Drugs Based on TGF-β1 Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Drugs Based on TGF-β1 Market Size by Region (2017-2022)
6.2 APAC Drugs Based on TGF-β1 Market Size by Type (2017-2022)
6.3 APAC Drugs Based on TGF-β1 Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Drugs Based on TGF-β1 by Country (2017-2022)
7.2 Europe Drugs Based on TGF-β1 Market Size by Type (2017-2022)
7.3 Europe Drugs Based on TGF-β1 Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Drugs Based on TGF-β1 by Region (2017-2022)
8.2 Middle East & Africa Drugs Based on TGF-β1 Market Size by Type (2017-2022)
8.3 Middle East & Africa Drugs Based on TGF-β1 Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Drugs Based on TGF-β1 Market Forecast
10.1 Global Drugs Based on TGF-β1 Forecast by Regions (2023-2028)
10.1.1 Global Drugs Based on TGF-β1 Forecast by Regions (2023-2028)
10.1.2 Americas Drugs Based on TGF-β1 Forecast
10.1.3 APAC Drugs Based on TGF-β1 Forecast
10.1.4 Europe Drugs Based on TGF-β1 Forecast
10.1.5 Middle East & Africa Drugs Based on TGF-β1 Forecast
10.2 Americas Drugs Based on TGF-β1 Forecast by Country (2023-2028)
10.2.1 United States Drugs Based on TGF-β1 Market Forecast
10.2.2 Canada Drugs Based on TGF-β1 Market Forecast
10.2.3 Mexico Drugs Based on TGF-β1 Market Forecast
10.2.4 Brazil Drugs Based on TGF-β1 Market Forecast
10.3 APAC Drugs Based on TGF-β1 Forecast by Region (2023-2028)
10.3.1 China Drugs Based on TGF-β1 Market Forecast
10.3.2 Japan Drugs Based on TGF-β1 Market Forecast
10.3.3 Korea Drugs Based on TGF-β1 Market Forecast
10.3.4 Southeast Asia Drugs Based on TGF-β1 Market Forecast
10.3.5 India Drugs Based on TGF-β1 Market Forecast
10.3.6 Australia Drugs Based on TGF-β1 Market Forecast
10.4 Europe Drugs Based on TGF-β1 Forecast by Country (2023-2028)
10.4.1 Germany Drugs Based on TGF-β1 Market Forecast
10.4.2 France Drugs Based on TGF-β1 Market Forecast
10.4.3 UK Drugs Based on TGF-β1 Market Forecast
10.4.4 Italy Drugs Based on TGF-β1 Market Forecast
10.4.5 Russia Drugs Based on TGF-β1 Market Forecast
10.5 Middle East & Africa Drugs Based on TGF-β1 Forecast by Region (2023-2028)
10.5.1 Egypt Drugs Based on TGF-β1 Market Forecast
10.5.2 South Africa Drugs Based on TGF-β1 Market Forecast
10.5.3 Israel Drugs Based on TGF-β1 Market Forecast
10.5.4 Turkey Drugs Based on TGF-β1 Market Forecast
10.5.5 GCC Countries Drugs Based on TGF-β1 Market Forecast
10.6 Global Drugs Based on TGF-β1 Forecast by Type (2023-2028)
10.7 Global Drugs Based on TGF-β1 Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 Roche
11.1.1 Roche Company Information
11.1.2 Roche Drugs Based on TGF-β1 Product Offered
11.1.3 Roche Drugs Based on TGF-β1 Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Roche Main Business Overview
11.1.5 Roche Latest Developments
11.2 Shionogi Ltd
11.2.1 Shionogi Ltd Company Information
11.2.2 Shionogi Ltd Drugs Based on TGF-β1 Product Offered
11.2.3 Shionogi Ltd Drugs Based on TGF-β1 Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Shionogi Ltd Main Business Overview
11.2.5 Shionogi Ltd Latest Developments
12 Research Findings and Conclusion
Table 1. Drugs Based on TGF-β1 Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Pirfenidone
Table 3. Major Players of Galunisertib
Table 4. Major Players of Others
Table 5. Drugs Based on TGF-β1 Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 6. Global Drugs Based on TGF-β1 Market Size by Type (2017-2022) & ($ Millions)
Table 7. Global Drugs Based on TGF-β1 Market Size Market Share by Type (2017-2022)
Table 8. Drugs Based on TGF-β1 Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 9. Global Drugs Based on TGF-β1 Market Size by Application (2017-2022) & ($ Millions)
Table 10. Global Drugs Based on TGF-β1 Market Size Market Share by Application (2017-2022)
Table 11. Global Drugs Based on TGF-β1 Revenue by Players (2020-2022) & ($ Millions)
Table 12. Global Drugs Based on TGF-β1 Revenue Market Share by Player (2020-2022)
Table 13. Drugs Based on TGF-β1 Key Players Head office and Products Offered
Table 14. Drugs Based on TGF-β1 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Drugs Based on TGF-β1 Market Size by Regions 2017-2022 & ($ Millions)
Table 18. Global Drugs Based on TGF-β1 Market Size Market Share by Regions (2017-2022)
Table 19. Americas Drugs Based on TGF-β1 Market Size by Country (2017-2022) & ($ Millions)
Table 20. Americas Drugs Based on TGF-β1 Market Size Market Share by Country (2017-2022)
Table 21. Americas Drugs Based on TGF-β1 Market Size by Type (2017-2022) & ($ Millions)
Table 22. Americas Drugs Based on TGF-β1 Market Size Market Share by Type (2017-2022)
Table 23. Americas Drugs Based on TGF-β1 Market Size by Application (2017-2022) & ($ Millions)
Table 24. Americas Drugs Based on TGF-β1 Market Size Market Share by Application (2017-2022)
Table 25. APAC Drugs Based on TGF-β1 Market Size by Region (2017-2022) & ($ Millions)
Table 26. APAC Drugs Based on TGF-β1 Market Size Market Share by Region (2017-2022)
Table 27. APAC Drugs Based on TGF-β1 Market Size by Type (2017-2022) & ($ Millions)
Table 28. APAC Drugs Based on TGF-β1 Market Size Market Share by Type (2017-2022)
Table 29. APAC Drugs Based on TGF-β1 Market Size by Application (2017-2022) & ($ Millions)
Table 30. APAC Drugs Based on TGF-β1 Market Size Market Share by Application (2017-2022)
Table 31. Europe Drugs Based on TGF-β1 Market Size by Country (2017-2022) & ($ Millions)
Table 32. Europe Drugs Based on TGF-β1 Market Size Market Share by Country (2017-2022)
Table 33. Europe Drugs Based on TGF-β1 Market Size by Type (2017-2022) & ($ Millions)
Table 34. Europe Drugs Based on TGF-β1 Market Size Market Share by Type (2017-2022)
Table 35. Europe Drugs Based on TGF-β1 Market Size by Application (2017-2022) & ($ Millions)
Table 36. Europe Drugs Based on TGF-β1 Market Size Market Share by Application (2017-2022)
Table 37. Middle East & Africa Drugs Based on TGF-β1 Market Size by Region (2017-2022) & ($ Millions)
Table 38. Middle East & Africa Drugs Based on TGF-β1 Market Size Market Share by Region (2017-2022)
Table 39. Middle East & Africa Drugs Based on TGF-β1 Market Size by Type (2017-2022) & ($ Millions)
Table 40. Middle East & Africa Drugs Based on TGF-β1 Market Size Market Share by Type (2017-2022)
Table 41. Middle East & Africa Drugs Based on TGF-β1 Market Size by Application (2017-2022) & ($ Millions)
Table 42. Middle East & Africa Drugs Based on TGF-β1 Market Size Market Share by Application (2017-2022)
Table 43. Key Market Drivers & Growth Opportunities of Drugs Based on TGF-β1
Table 44. Key Market Challenges & Risks of Drugs Based on TGF-β1
Table 45. Key Industry Trends of Drugs Based on TGF-β1
Table 46. Global Drugs Based on TGF-β1 Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 47. Global Drugs Based on TGF-β1 Market Size Market Share Forecast by Regions (2023-2028)
Table 48. Global Drugs Based on TGF-β1 Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 49. Global Drugs Based on TGF-β1 Market Size Market Share Forecast by Type (2023-2028)
Table 50. Global Drugs Based on TGF-β1 Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 51. Global Drugs Based on TGF-β1 Market Size Market Share Forecast by Application (2023-2028)
Table 52. Roche Details, Company Type, Drugs Based on TGF-β1 Area Served and Its Competitors
Table 53. Roche Drugs Based on TGF-β1 Product Offered
Table 54. Roche Drugs Based on TGF-β1 Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 55. Roche Main Business
Table 56. Roche Latest Developments
Table 57. Shionogi Ltd Details, Company Type, Drugs Based on TGF-β1 Area Served and Its Competitors
Table 58. Shionogi Ltd Drugs Based on TGF-β1 Product Offered
Table 59. Shionogi Ltd Main Business
Table 60. Shionogi Ltd Drugs Based on TGF-β1 Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 61. Shionogi Ltd Latest Developments
List of Figures
Figure 1. Drugs Based on TGF-β1 Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Drugs Based on TGF-β1 Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Drugs Based on TGF-β1 Market Size Market Share by Type in 2021
Figure 7. Drugs Based on TGF-β1 in IPF
Figure 8. Global Drugs Based on TGF-β1 Market: IPF (2017-2022) & ($ Millions)
Figure 9. Drugs Based on TGF-β1 in Cancer
Figure 10. Global Drugs Based on TGF-β1 Market: Cancer (2017-2022) & ($ Millions)
Figure 11. Drugs Based on TGF-β1 in Others
Figure 12. Global Drugs Based on TGF-β1 Market: Others (2017-2022) & ($ Millions)
Figure 13. Global Drugs Based on TGF-β1 Market Size Market Share by Application in 2021
Figure 14. Global Drugs Based on TGF-β1 Revenue Market Share by Player in 2021
Figure 15. Global Drugs Based on TGF-β1 Market Size Market Share by Regions (2017-2022)
Figure 16. Americas Drugs Based on TGF-β1 Market Size 2017-2022 ($ Millions)
Figure 17. APAC Drugs Based on TGF-β1 Market Size 2017-2022 ($ Millions)
Figure 18. Europe Drugs Based on TGF-β1 Market Size 2017-2022 ($ Millions)
Figure 19. Middle East & Africa Drugs Based on TGF-β1 Market Size 2017-2022 ($ Millions)
Figure 20. Americas Drugs Based on TGF-β1 Value Market Share by Country in 2021
Figure 21. Americas Drugs Based on TGF-β1 Consumption Market Share by Type in 2021
Figure 22. Americas Drugs Based on TGF-β1 Market Size Market Share by Application in 2021
Figure 23. United States Drugs Based on TGF-β1 Market Size Growth 2017-2022 ($ Millions)
Figure 24. Canada Drugs Based on TGF-β1 Market Size Growth 2017-2022 ($ Millions)
Figure 25. Mexico Drugs Based on TGF-β1 Market Size Growth 2017-2022 ($ Millions)
Figure 26. Brazil Drugs Based on TGF-β1 Market Size Growth 2017-2022 ($ Millions)
Figure 27. APAC Drugs Based on TGF-β1 Market Size Market Share by Region in 2021
Figure 28. APAC Drugs Based on TGF-β1 Market Size Market Share by Application in 2021
Figure 29. China Drugs Based on TGF-β1 Market Size Growth 2017-2022 ($ Millions)
Figure 30. Japan Drugs Based on TGF-β1 Market Size Growth 2017-2022 ($ Millions)
Figure 31. Korea Drugs Based on TGF-β1 Market Size Growth 2017-2022 ($ Millions)
Figure 32. Southeast Asia Drugs Based on TGF-β1 Market Size Growth 2017-2022 ($ Millions)
Figure 33. India Drugs Based on TGF-β1 Market Size Growth 2017-2022 ($ Millions)
Figure 34. Australia Drugs Based on TGF-β1 Market Size Growth 2017-2022 ($ Millions)
Figure 35. Europe Drugs Based on TGF-β1 Market Size Market Share by Country in 2021
Figure 36. Europe Drugs Based on TGF-β1 Market Size Market Share by Type in 2021
Figure 37. Europe Drugs Based on TGF-β1 Market Size Market Share by Application in 2021
Figure 38. Germany Drugs Based on TGF-β1 Market Size Growth 2017-2022 ($ Millions)
Figure 39. France Drugs Based on TGF-β1 Market Size Growth 2017-2022 ($ Millions)
Figure 40. UK Drugs Based on TGF-β1 Market Size Growth 2017-2022 ($ Millions)
Figure 41. Italy Drugs Based on TGF-β1 Market Size Growth 2017-2022 ($ Millions)
Figure 42. Russia Drugs Based on TGF-β1 Market Size Growth 2017-2022 ($ Millions)
Figure 43. Middle East & Africa Drugs Based on TGF-β1 Market Size Market Share by Region in 2021
Figure 44. Middle East & Africa Drugs Based on TGF-β1 Market Size Market Share by Type in 2021
Figure 45. Middle East & Africa Drugs Based on TGF-β1 Market Size Market Share by Application in 2021
Figure 46. Egypt Drugs Based on TGF-β1 Market Size Growth 2017-2022 ($ Millions)
Figure 47. South Africa Drugs Based on TGF-β1 Market Size Growth 2017-2022 ($ Millions)
Figure 48. Israel Drugs Based on TGF-β1 Market Size Growth 2017-2022 ($ Millions)
Figure 49. Turkey Drugs Based on TGF-β1 Market Size Growth 2017-2022 ($ Millions)
Figure 50. GCC Country Drugs Based on TGF-β1 Market Size Growth 2017-2022 ($ Millions)
Figure 51. Americas Drugs Based on TGF-β1 Market Size 2023-2028 ($ Millions)
Figure 52. APAC Drugs Based on TGF-β1 Market Size 2023-2028 ($ Millions)
Figure 53. Europe Drugs Based on TGF-β1 Market Size 2023-2028 ($ Millions)
Figure 54. Middle East & Africa Drugs Based on TGF-β1 Market Size 2023-2028 ($ Millions)
Figure 55. United States Drugs Based on TGF-β1 Market Size 2023-2028 ($ Millions)
Figure 56. Canada Drugs Based on TGF-β1 Market Size 2023-2028 ($ Millions)
Figure 57. Mexico Drugs Based on TGF-β1 Market Size 2023-2028 ($ Millions)
Figure 58. Brazil Drugs Based on TGF-β1 Market Size 2023-2028 ($ Millions)
Figure 59. China Drugs Based on TGF-β1 Market Size 2023-2028 ($ Millions)
Figure 60. Japan Drugs Based on TGF-β1 Market Size 2023-2028 ($ Millions)
Figure 61. Korea Drugs Based on TGF-β1 Market Size 2023-2028 ($ Millions)
Figure 62. Southeast Asia Drugs Based on TGF-β1 Market Size 2023-2028 ($ Millions)
Figure 63. India Drugs Based on TGF-β1 Market Size 2023-2028 ($ Millions)
Figure 64. Australia Drugs Based on TGF-β1 Market Size 2023-2028 ($ Millions)
Figure 65. Germany Drugs Based on TGF-β1 Market Size 2023-2028 ($ Millions)
Figure 66. France Drugs Based on TGF-β1 Market Size 2023-2028 ($ Millions)
Figure 67. UK Drugs Based on TGF-β1 Market Size 2023-2028 ($ Millions)
Figure 68. Italy Drugs Based on TGF-β1 Market Size 2023-2028 ($ Millions)
Figure 69. Russia Drugs Based on TGF-β1 Market Size 2023-2028 ($ Millions)
Figure 70. Spain Drugs Based on TGF-β1 Market Size 2023-2028 ($ Millions)
Figure 71. Egypt Drugs Based on TGF-β1 Market Size 2023-2028 ($ Millions)
Figure 72. South Africa Drugs Based on TGF-β1 Market Size 2023-2028 ($ Millions)
Figure 73. Israel Drugs Based on TGF-β1 Market Size 2023-2028 ($ Millions)
Figure 74. Turkey Drugs Based on TGF-β1 Market Size 2023-2028 ($ Millions)
Figure 75. GCC Countries Drugs Based on TGF-β1 Market Size 2023-2028 ($ Millions)
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...